![](/img/cover-not-exists.png)
Clinical outcomes and survival surrogacy studies of prostate-specific antigen declines following enzalutamide in men with metastatic castration-resistant prostate cancer previously treated with docetaxel
Armstrong, Andrew J., Saad, Fred, Phung, De, Dmuchowski, Carl, Shore, Neal D., Fizazi, Karim, Hirmand, Mohammad, Forer, David, Scher, Howard I., Bono, Johann DeLanguage:
english
Journal:
Cancer
DOI:
10.1002/cncr.30587
Date:
February, 2017
File:
PDF, 605 KB
english, 2017